Govt in talks with industry on production of Gilead's remdesivir for trials

Checks with industry on when can production begin here for trials

As trials of anti-viral drugs gain momentum, the government has now turned its focus on ensuring that remdesivir, Gilead's repurposed Ebola drug, is available here for trials.

US Food and Drug Administration (FDA) has already given an emergency approval to the drug for its trials on coronavirus infected patients. This has piqued Indian authorities' interest in conducting trials on patients here. "Our clinicians can use remdesivir on patients here on compassionate grounds. However, the drug needs to be available. It is a patented drug and we understand it is complex to make as well," said a senior government official.

He